S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
BAC   42.14 (+1.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
BAC   42.14 (+1.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
BAC   42.14 (+1.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
BAC   42.14 (+1.08%)
NYSE:GPX

GP Strategies Stock Forecast, Price & News

$20.70
0.00 (0.00 %)
(As of 09/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$20.70
$20.75
50-Day Range
$20.22
$20.74
52-Week Range
$8.85
$20.91
Volume43,728 shs
Average Volume105,950 shs
Market Capitalization$363.31 million
P/E Ratio28.36
Dividend YieldN/A
Beta1.64
30 days | 90 days | 365 days | Advanced Chart
Receive GPX News and Ratings via Email

Sign-up to receive the latest news and ratings for GP Strategies and its competitors with MarketBeat's FREE daily newsletter.


GP Strategies logo

About GP Strategies

GP Strategies Corp. provides training, e-Learning solutions, management consulting and engineering services. It operates through the following Geographic Segments: North America, EMEA and Emerging Markets (Latin America and Asia Pacific countries). It provides Workforce Transformation Services into three primary solution sets: Organizational Performance Solutions (OPS), Technical Performance Solutions (TPS) and Automotive Performance Solutions (APS). The company was founded in 1959 and is headquartered in Columbia, MD.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.04 out of 5 stars

Consumer Discretionary Sector

170th out of 384 stocks

Educational Services Industry

16th out of 50 stocks

Analyst Opinion: 1.0Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











GP Strategies (NYSE:GPX) Frequently Asked Questions

Is GP Strategies a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GP Strategies in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" GP Strategies stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GPX, but not buy additional shares or sell existing shares.
View analyst ratings for GP Strategies
or view top-rated stocks.

What stocks does MarketBeat like better than GP Strategies?

Wall Street analysts have given GP Strategies a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but GP Strategies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting GP Strategies?

GP Strategies saw a increase in short interest in August. As of August 31st, there was short interest totaling 392,500 shares, an increase of 21.6% from the August 15th total of 322,700 shares. Based on an average daily volume of 177,000 shares, the days-to-cover ratio is currently 2.2 days. Currently, 2.4% of the shares of the company are short sold.
View GP Strategies' Short Interest
.

When is GP Strategies' next earnings date?

GP Strategies is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for GP Strategies
.

How were GP Strategies' earnings last quarter?

GP Strategies Co. (NYSE:GPX) released its earnings results on Sunday, August, 8th. The company reported $0.33 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.23 by $0.10. The business earned $128.78 million during the quarter, compared to analyst estimates of $127.29 million. GP Strategies had a net margin of 2.73% and a trailing twelve-month return on equity of 9.09%.
View GP Strategies' earnings history
.

How has GP Strategies' stock been impacted by COVID-19?

GP Strategies' stock was trading at $7.82 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, GPX stock has increased by 164.7% and is now trading at $20.70.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for GPX?

3 brokers have issued 12 month price objectives for GP Strategies' stock. Their forecasts range from $20.00 to $23.00. On average, they expect GP Strategies' share price to reach $21.28 in the next twelve months. This suggests a possible upside of 2.8% from the stock's current price.
View analysts' price targets for GP Strategies
or view top-rated stocks among Wall Street analysts.

Who are GP Strategies' key executives?

GP Strategies' management team includes the following people:
  • Adam Henry Stedham, President, Chief Executive Officer & Director
  • Michael R. Dugan, Chief Financial Officer & Executive Vice President
  • Matt Young, SVP, Chief Information & Security Officer
  • James L. Galante, Secretary, Senior Vice President & General Counsel
  • Matt Donovan, SVP, Chief Learning & Innovation Officer

What is Adam H. Stedham's approval rating as GP Strategies' CEO?

14 employees have rated GP Strategies CEO Adam H. Stedham on Glassdoor.com. Adam H. Stedham has an approval rating of 76% among GP Strategies' employees.

What other stocks do shareholders of GP Strategies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GP Strategies investors own include Bravura Solutions (BVS), Northstar Realty Europe (NRE), Maxar Technologies (MAXR), AT&T (T), Verizon Communications (VZ), General Motors (GM), Alphabet (GOOG), Pfizer (PFE), Exxon Mobil (XOM) and AbbVie (ABBV).

What is GP Strategies' stock symbol?

GP Strategies trades on the New York Stock Exchange (NYSE) under the ticker symbol "GPX."

Who are GP Strategies' major shareholders?

GP Strategies' stock is owned by many different retail and institutional investors. Top institutional shareholders include Cove Street Capital LLC (9.29%), Dimensional Fund Advisors LP (6.83%), BlackRock Inc. (5.06%), Vanguard Group Inc. (3.94%), Minerva Advisors LLC (1.98%) and Engine Capital Management LP (1.74%). Company insiders that own GP Strategies stock include Hoskins Philip and Russell L Becker.
View institutional ownership trends for GP Strategies
.

Which major investors are selling GP Strategies stock?

GPX stock was sold by a variety of institutional investors in the last quarter, including Cove Street Capital LLC, Russell Investments Group Ltd., JPMorgan Chase & Co., BlackRock Inc., Vanguard Group Inc., Engine Capital Management LP, Boston Partners, and Bank of America Corp DE.
View insider buying and selling activity for GP Strategies
or view top insider-selling stocks.

Which major investors are buying GP Strategies stock?

GPX stock was acquired by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC, Franklin Resources Inc., ClariVest Asset Management LLC, Citadel Advisors LLC, Seizert Capital Partners LLC, Minerva Advisors LLC, Prudential Financial Inc., and Millennium Management LLC.
View insider buying and selling activity for GP Strategies
or or view top insider-buying stocks.

How do I buy shares of GP Strategies?

Shares of GPX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is GP Strategies' stock price today?

One share of GPX stock can currently be purchased for approximately $20.70.

How much money does GP Strategies make?

GP Strategies has a market capitalization of $363.31 million and generates $473.11 million in revenue each year. The company earns $7.07 million in net income (profit) each year or $0.73 on an earnings per share basis.

How many employees does GP Strategies have?

GP Strategies employs 4,343 workers across the globe.

What is GP Strategies' official website?

The official website for GP Strategies is www.gpstrategies.com.

Where are GP Strategies' headquarters?

How can I contact GP Strategies?

GP Strategies' mailing address is 70 CORPORATE CENTER 11000 BROKEN LAND PARKWAY SUITE 200, COLUMBIA MD, 21044. The company can be reached via phone at (443) 367-9600 or via email at [email protected].


This page was last updated on 9/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.